Clinical Trial Update: A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of SHR1701 plus chemotherapy for gastric or gastroesophageal junction cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• SHR1701

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Gastric or Gastroesophageal Junction Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING